Abrdn Life Sciences Investors
US ˙ NYSE ˙ US87911K1007

SecurityHQL / Abrdn Life Sciences Investors
InstitutionUsca Ria Llc
Latest Disclosed Ownership17,195 shares
Latest Disclosed Value $ 369,000
Usca Ria Llc reports 15.40% decrease in ownership of HQL / Abrdn Life Sciences Investors

On July 28, 2021 - Usca Ria Llc filed a 13F-HR form disclosing ownership of 17,195 shares of Abrdn Life Sciences Investors (US:HQL) valued at $368,661 USD as of June 30, 2021. The entity filed a previous 13F-HR on April 27, 2021 disclosing 20,325 shares of Abrdn Life Sciences Investors. This represents a change in shares of -15.40% during the quarter. The current value of the position is $290,939 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2021-07-28 2021-06-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 17,195 -3,130 -15.40 369 -7.98 0.0224
2021-04-27 2021-03-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 20,325 -14,626 -41.85 401 -41.88 0.0264
2021-01-27 2020-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 34,951 10 0.03 690 12.38 0.0484
2020-10-27 2020-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 34,941 34,071 3,916.21 614 4,623.08 0.0481
2019-10-31 2019-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT COM 87911K100 870 870 13 0.0013
2017-02-09 2016-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 0 -17,880 -100.00 0 -100.00
2016-11-15 2016-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 17,880 -1,300 -6.78 335 1.52 0.0555
2016-08-13 2016-06-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 19,180 -136,114 -87.65 330 -96.19 0.0554
2016-05-16 2016-03-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 155,294 119,415 332.83 8,656 920.75 0.0652
2016-02-08 2015-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 35,879 6,766 23.24 848 29.47 0.1832
2015-11-13 2015-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 29,113 1,304 4.69 655 -16.45 0.1644
2015-09-17 2015-06-30 13F/A-1 TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 27,809 17,957 182.27 784 188.24 0.2079
2015-09-17 2015-03-31 13F/A-1 TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 9,852 -16,050 -61.96 272 -57.76 0.0729
2015-02-11 2014-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 25,902 644
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.